Biomarker Tech counts on "big jump" in evidence for breast cancer test
This article was originally published in Clinica
Executive Summary
Biomarker Technologies is about to start clinical trials of its blood test for breast cancer. Previous studies have shown that the test is better at detecting the disease than the mammogram, claims the US firm.